| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers N > Headlines for Nabi Biopharmaceuticals > News item |
Nabi Biopharmaceuticals investor buys 122,100 shares
By Lisa Kerner
Charlotte, N.C., Jan. 27 - Dorset Management Corp. increased its ownership interest in Nabi Biopharmaceuticals to 10.1% with the purchase of 122,100 shares on Jan. 9 and Jan. 12.
Each share was priced at $3.82 or $3.83 for a total of $467,007, according to a schedule 13D/A filed with the Securities and Exchange Commission.
Dorset beneficially owns 5,265,453 shares of the Boca Raton, Fla., pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.